Nostos Genomics is on a mission to improve the lives of the 400 million people around the world who have a genetic disease.
To diagnose a genetic disease, PhD-trained analysts employed by genetic testing labs currently spend on average 2 days investigating a single patient’s genetic mutations. Because of this, hundreds of labs around the world have limited throughput, profit margins and diagnostic yield, while struggling to capture the sky-rocketing demand for genetic tests.
Nostos Genomics automated this process with a patent-pending technology combining explainable AI and synthetic biology and built the first cloud platform for genetic mutation analysis that takes less than 2 minutes until diagnosis while being fully interpretable by humans. Our platform is validated with >5K patient cases, contains >100M mutations and is already used by 4 genetic testing centers as part of our early access program, with one of the largest in Europe among them
CEO, Nostos Genomics
Experienced with medical ML products and in the healthcare industry
Rocio Acuna Hidalgo
CTO, Nostos Genomics
Medical doctor with PhD in human genetics, previously Max Planck Institute